253 related articles for article (PubMed ID: 21124888)
1. Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study.
French MD; Churcher TS; Gambhir M; Fenwick A; Webster JP; Kabatereine NB; Basáñez MG
PLoS Negl Trop Dis; 2010 Nov; 4(11):e897. PubMed ID: 21124888
[TBL] [Abstract][Full Text] [Related]
2. Estimation of changes in the force of infection for intestinal and urogenital schistosomiasis in countries with schistosomiasis control initiative-assisted programmes.
French MD; Churcher TS; Webster JP; Fleming FM; Fenwick A; Kabatereine NB; Sacko M; Garba A; Toure S; Nyandindi U; Mwansa J; Blair L; Bosqué-Oliva E; Basáñez MG
Parasit Vectors; 2015 Oct; 8():558. PubMed ID: 26499981
[TBL] [Abstract][Full Text] [Related]
3. Increasing teacher motivation and supervision is an important but not sufficient strategy for improving praziquantel uptake in Schistosoma mansoni control programs: serial cross sectional surveys in Uganda.
Muhumuza S; Katahoire A; Nuwaha F; Olsen A
BMC Infect Dis; 2013 Dec; 13():590. PubMed ID: 24330594
[TBL] [Abstract][Full Text] [Related]
4. Repeated praziquantel treatments remodel the genetic and spatial landscape of schistosomiasis risk and transmission.
Barbosa LM; Reis EA; Dos Santos CR; Costa JM; Carmo TM; Aminu PT; Pitanga TN; Ponce-Terashima R; Blank WA; Silva LK; Reis MG; Blanton RE
Int J Parasitol; 2016 May; 46(5-6):343-50. PubMed ID: 26953255
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali.
Deol A; Webster JP; Walker M; Basáñez MG; Hollingsworth TD; Fleming FM; Montresor A; French MD
Parasit Vectors; 2016 Oct; 9(1):543. PubMed ID: 27729063
[TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.
Bustinduy AL; Waterhouse D; de Sousa-Figueiredo JC; Roberts SA; Atuhaire A; Van Dam GJ; Corstjens PL; Scott JT; Stanton MC; Kabatereine NB; Ward S; Hope WW; Stothard JR
mBio; 2016 Aug; 7(4):. PubMed ID: 27507822
[TBL] [Abstract][Full Text] [Related]
7. Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda.
Faust CL; Crotti M; Moses A; Oguttu D; Wamboko A; Adriko M; Adekanle EK; Kabatereine N; Tukahebwa EM; Norton AJ; Gower CM; Webster JP; Lamberton PHL
Parasit Vectors; 2019 Dec; 12(1):607. PubMed ID: 31881923
[TBL] [Abstract][Full Text] [Related]
8. Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial.
Nalugwa A; Nuwaha F; Tukahebwa EM; Olsen A
PLoS Negl Trop Dis; 2015 May; 9(5):e0003796. PubMed ID: 26011733
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda.
Tukahebwa EM; Vennervald BJ; Nuwaha F; Kabatereine NB; Magnussen P
Trans R Soc Trop Med Hyg; 2013 Jun; 107(6):397-404. PubMed ID: 23596262
[TBL] [Abstract][Full Text] [Related]
10. Application of Schistosomiasis Consortium for Operational Research and Evaluation Study Findings to Refine Predictive Modeling of
King CH; Yoon N; Wang X; Lo NC; Alsallaq R; Ndeffo-Mbah M; Li E; Gurarie D
Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):97-104. PubMed ID: 32400357
[TBL] [Abstract][Full Text] [Related]
11. Impact of two rounds of praziquantel mass drug administration on Schistosoma mansoni infection prevalence and intensity: a comparison between community wide treatment and school based treatment in western Kenya.
Onkanga IO; Mwinzi PN; Muchiri G; Andiego K; Omedo M; Karanja DM; Wiegand RE; Secor WE; Montgomery SP
Int J Parasitol; 2016 Jun; 46(7):439-45. PubMed ID: 26940547
[TBL] [Abstract][Full Text] [Related]
12. Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration.
Crellen T; Walker M; Lamberton PH; Kabatereine NB; Tukahebwa EM; Cotton JA; Webster JP
Clin Infect Dis; 2016 Nov; 63(9):1151-1159. PubMed ID: 27470241
[TBL] [Abstract][Full Text] [Related]
13. Praziquantel Treatment of
Nono JK; Mpotje T; Mosala P; Aziz NA; Musaigwa F; Hlaka L; Spangenberg T; Brombacher F
Front Immunol; 2021; 12():748387. PubMed ID: 34956183
[TBL] [Abstract][Full Text] [Related]
14. Performance and safety of praziquantel for treatment of intestinal schistosomiasis in infants and preschool children.
Sousa-Figueiredo JC; Betson M; Atuhaire A; Arinaitwe M; Navaratnam AM; Kabatereine NB; Bickle Q; Stothard JR
PLoS Negl Trop Dis; 2012; 6(10):e1864. PubMed ID: 23094120
[TBL] [Abstract][Full Text] [Related]
15. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme.
Gower CM; Gehre F; Marques SR; Lamberton PHL; Lwambo NJ; Webster JP
Parasit Vectors; 2017 Dec; 10(1):593. PubMed ID: 29197426
[TBL] [Abstract][Full Text] [Related]
19. Mass drug administration with praziquantel reduces the prevalence of Schistosoma mansoni and improves liver morbidity in untreated preschool children.
Cleland CR; Tukahebwa EM; Fenwick A; Blair L
Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):575-81. PubMed ID: 25059523
[TBL] [Abstract][Full Text] [Related]
20. Comparison of School-Based and Community-Wide Mass Drug Administration for Schistosomiasis Control in an Area of Western Kenya with High Initial
Secor WE; Wiegand RE; Montgomery SP; Karanja DMS; Odiere MR
Am J Trop Med Hyg; 2020 Feb; 102(2):318-327. PubMed ID: 31802733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
